David Lindley

The EED protein–protein interaction inhibitor A-395 inactivates the PRC2 complex

Yupeng He, Sujatha Selvaraju, Michael L. Curtin et al. · Nature Chemical Biology · 2017 · 229 citations · Full text

Protein Function, Signal Transduction, Molecular Regulation +7

ABC and SLC Transporter Expression and Pot Substrate Characterization across the Human CMEC/D3 Blood−Brain Barrier Cell Line

Stephen M. Carl, David Lindley, P. O. Couraud et al. · Molecular Pharmaceutics · 2010 · 96 citations · Full text

Head-To-Head Comparison of Different Solubility-Enabling Formulations of Etoposide and Their Consequent Solubility–Permeability Interplay

Avital Beig, Jonathan M. Miller, David Lindley et al. · Journal of Pharmaceutical Sciences · 2015 · 77 citations

Medicine, Solution (Chemistry), Analytical Chemistry +6

Mechanistic Physiologically Based Pharmacokinetic Modeling of the Dissolution and Food Effect of a Biopharmaceutics Classification System IV Compound—The Venetoclax Story

Arian Emami Riedmaier, David Lindley, Jeffrey A. Hall et al. · Journal of Pharmaceutical Sciences · 2017 · 76 citations

Systems Pharmacology, Pharmaceutical Science, Pharmacokinetic Modeling +9

Advantageous Solubility-Permeability Interplay When Using Amorphous Solid Dispersion (ASD) Formulation for the BCS Class IV P-gp Substrate Rifaximin: Simultaneous Increase of Both the Solubility and the Permeability

Avital Beig, Noa Fine‐Shamir, David Lindley et al. · The AAPS Journal · 2017 · 59 citations · Full text

Materials Science, Simultaneous Increase, Engineering +6